Viimased lisandused - Retina Vascular Occlusions
|
Hemi-CRVO - dual trunk veinvaatamisi: 11681 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 14181 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 11881 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 11881 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 11381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13281 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12681 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 15781 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13581 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12681 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 12281 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 11381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 16381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 14681 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 15881 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 15681 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 11381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 11281 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 15381 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 11581 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 13281 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
Hemi-CRVO - dual trunk veinvaatamisi: 10681 year old female mild vision loss - Anatomy shows dual trunk vein with one blocked. About 20 percent of people have this anatomydets 17, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 15878 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 13278 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 17078 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 15578 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 12678 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 12078 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 15878 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 12678 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 13578 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 12578 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 15178 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 14578 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 13778 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
BRAO - plaques in vessels - GIF video of FAvaatamisi: 11678 year old female with vision loss for 1 week and old macular scar. Images show BRAO with plaques and FA shows occlusion.okt 13, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 13957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 10157 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 13857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 11457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 9557 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 12257 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 9857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 12057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 10257 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 11857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 15257 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 10157 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 10757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 13257 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 12457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 15057 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 11757 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 12957 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 11457 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 10857 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
Central Retinal Vein Occlusion - Non-Ischemic - Excellent Outcomevaatamisi: 13257 year old man The right eye has had vision loss for about 3 weeks. He woke up with vision loss.
Medical Hx: HIV . Diabetes Mellitus (since 2014). Thyroid Disease.
Systemic Meds: gemboya. Metformin Hydrochloride. trulicity. losartan. vesepa. Synthroid .
VA OD: sc20/160 OS: sc20/20
TP: OD:14 OS:14
Treated with Avastin
VA 6 weeks later 20/32 – dry one shot.
Missed follow-up after second treatment and came 5 months later with good vision and no macular edemaaug 17, 2025
|
|
CRAO and NVI (rubeosis)vaatamisi: 103aug 13, 2025
|
|
CRAO and NVI (rubeosis)vaatamisi: 148aug 13, 2025
|
|
BRVO with good visionvaatamisi: 36887 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 38887 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 35887 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 18687 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 15787 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 14287 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 16287 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 20487 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 15587 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 13787 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 16587 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 16987 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 17887 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 14887 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 20487 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 16787 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 17787 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 16987 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 16487 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 15587 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
BRVO with good visionvaatamisi: 19387 year old man with good vision (diabetes without retinopathy). VA 20/25 OU. Vision never worsened from BRVO OS.juuli 27, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 18063 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 19163 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 17063 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 18163 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 15663 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 19363 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 15463 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 15863 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 24063 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 15863 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 15563 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 17563 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 17163 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 16663 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 19663 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 16963 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 15563 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 16263 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
Central Retinal Vein Occlusion with cilioretinal artery occlusionvaatamisi: 18863 year old female who lost vision in the left eye 2 days ago. She was in the emergency room and had a lot of tests done which were all reportedly normal. The right eye is OK.
VA OD: Dcc20/25 NccJ2
VA OS: Dcc20/200-1 PHNI Ncc20/400-1
IOP: TP: OD:11 OS:12juuli 22, 2024
|
|
|
|
